loadpatents
name:-0.003741979598999
name:-0.023431062698364
name:-0.003262996673584
ONO PHARMACEUTICALS CO., LTD. Patent Filings

ONO PHARMACEUTICALS CO., LTD.

Patent Applications and Registrations

Patent applications and USPTO patent grants for ONO PHARMACEUTICALS CO., LTD..The latest application filed is for "method for producing bicyclic compound".

Company Profile
3.20.5
  • ONO PHARMACEUTICALS CO., LTD. - Osaka JP
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Quinoline derivative
Grant 10,501,442 - Inukai , et al. Dec
2019-12-10
Method For Producing Bicyclic Compound
App 20190315705 - MORIGUCHI; Hideki ;   et al.
2019-10-17
Methods of producing anamorelin hydrochloride having controlled chloride content
Grant 9,403,867 - Kuwabe , et al. August 2, 2
2016-08-02
Bicyclic compound and use thereof for medical purposes
Grant 9,388,157 - Kambe , et al. July 12, 2
2016-07-12
Novel Compound And Medical Use Thereof
App 20140187630 - KOKUBO; Masaya ;   et al.
2014-07-03
Pharmaceutical composition for treatment of disease due to vascular constriction or vasodilation
Grant 8,765,783 - Nakade , et al. July 1, 2
2014-07-01
Compound and medical use thereof
Grant 8,748,485 - Kokubo , et al. June 10, 2
2014-06-10
Bicyclic compound and use thereof for medical purposes
Grant 8,614,340 - Kambe , et al. December 24, 2
2013-12-24
Novel Compound And Medical Use Thereof
App 20130245074 - Kokubo; Masaya ;   et al.
2013-09-19
Ethynylindole compounds
Grant 8,115,014 - Ohmoto , et al. February 14, 2
2012-02-14
Nitrogen-containing heterocyclic compound and pharmaceutical application thereof
Grant 7,968,572 - Nakai , et al. June 28, 2
2011-06-28
N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation
Grant 7,629,369 - Naganawa , et al. December 8, 2
2009-12-08
Spiro-piperidine compounds and medicinal use thereof
Grant 7,498,323 - Nishizawa , et al. March 3, 2
2009-03-03
Remedy for chronic disease
Grant 7,300,917 - Nakade , et al. November 27, 2
2007-11-27
Indole derivatives
Grant 7,291,644 - Torisu , et al. November 6, 2
2007-11-06
Pharmaceutical composition for treatment for urinary diseases comprising LPA receptor regulator
Grant 7,288,558 - Nakade , et al. October 30, 2
2007-10-30
Drugs containing triazaspiro[5.5]undecane derivatives as the active ingredient
Grant 7,285,552 - Mitsuya , et al. October 23, 2
2007-10-23
Human and mammalian stem cell-derived neuron survival factors
Grant 7,273,725 - Honjo , et al. September 25, 2
2007-09-25
Freeze-dried preparation of n[o-(p-pivaloyloxybenzenasulfonylamino) benzoyl] glycine monosodium salt tetrahydrate and process for producing same
Grant 7,262,317 - Takada , et al. August 28, 2
2007-08-28
Hydroxamic acid derivatives, process for the production thereof and drug containing the same as the active ingredient
Grant 6,770,644 - Konno , et al. August 3, 2
2004-08-03
11,15-O-dialkylprostaglandin E derivatives, process for producing the same, and drugs containing the same as the active ingredient
Grant 6,288,119 - Ohuchida , et al. September 11, 2
2001-09-11
Fused phenol derivatives
Grant 5,750,544 - Ohuchida , et al. May 12, 1
1998-05-12
Fused phenol derivatives
Grant 5,534,536 - Ohuchida , et al. July 9, 1
1996-07-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed